Knowledge Center

Patent / Jan 01, 1973

16.beta.-Methyl-17.alpha.-hydroxypregna-1,4,9(11)-triene-3,20-dione

Authors:
  • Ivan Villax
Source:
US 3761498

Pregnatrienedione I was prepd. from pregnanone II by KBH4 redn. followed by successive dehydration, methylation, bromination, and debromination.

Also in the Knowledge Center

Related Content

Devices

ËÄÉ«AV offers simple, patented and globally competitive dry powder inhalers – Disposable, Capsule, Blister and Large Dose DPIs – which are available for fully integrated turn-key development with formulation and for licensing.

Page
Read more

Continuous Tableting - Virtual Visit

Welcome to the future of drug product development

Page
Read more

·¡±è¾±»å±ð±ôâ„¢

·¡±è¾±»å±ð±ôâ„¢ is an innovative technology with the ability to deliver sustained-release pharmaceuticals via surface erosion resulting in the ability to precisely tune pharmacokinetics to meet the target indication needs.

Page
Read more